Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use. - Wikidata - wikimedia - TriplyDB

Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.

Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.

http://www.wikidata.org/entity/Q37763371

about

Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke The effects of estrogen in ischemic stroke Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.Pai-1 gene variants and COC use are associated with stroke risk: a case-control study in the Han Chinese women.Stroke Risk Factors Unique to Women.Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction.Evaluation of the coagulation profile among oral and vaginal combined hormonal contraceptive users using sonoclot coagulation analyzer.Increased risk of stroke in oral contraceptive users carried replicated genetic variants: a population-based case-control study in China.

P2860

Q24187746-89A3F159-F999-412F-88AD-D0BA79581C05 Q24198194-A059D6C9-6DEF-49D3-A969-18F1BE8D547D Q28384880-EA7BA425-6E3D-4A2D-A207-9F16C4D621BA Q33728471-FED1E77E-37CC-4847-A02F-06594F63E064 Q48534957-2616F0D2-B1F3-45D4-87F1-654B88914CA9 Q50042766-023A294A-7FF4-4BD3-8225-E55DD2DEC060 Q51277146-AB2E0C32-9594-442A-8774-42914826AB00 Q51365511-F9A2ABDF-18B3-4018-9828-9FCB0B190E19 Q54316156-36256232-6F8A-44AD-BEE7-2C3776E88C02

P2860

Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.

http://www.wikidata.org/entity/Q37763371

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 June 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Risk factors for heart attack, ...... th hormonal contraceptive use.

@en

Risk factors for heart attack, ...... th hormonal contraceptive use.

@nl

type

label

Risk factors for heart attack, ...... th hormonal contraceptive use.

@en

Risk factors for heart attack, ...... th hormonal contraceptive use.

@nl

prefLabel

Risk factors for heart attack, ...... th hormonal contraceptive use.

@en

Risk factors for heart attack, ...... th hormonal contraceptive use.

@nl

P1433

Q37763371-AC2973A7-0509-4E4B-ADF5-46BD08871CB6

P1476

Q37763371-E8568954-6A7C-42CA-A076-3C5C86860940

P2093

Q37763371-1DDE41D0-C43A-4768-9AAB-FFF2E49E07DF

Q37763371-2FE7447C-96BB-4DAB-80CB-7F866E8EDA45

Q37763371-307F5B78-ADD9-49BC-8037-E22915E820D1

Q37763371-35A498D7-6695-4E2F-AD96-21CF3576B2CB

Q37763371-B948D57B-F878-494B-8CF9-6D3A9CF30D8D

Q37763371-C0CAA819-E1D1-4C12-8E5A-D1DB6CF88FA8

Q37763371-D5F5053B-D4B9-4386-BFFF-F27E50553110

Q37763371-F49EF516-DF15-4FD5-9A11-5285EB4A0D15

P2860

Q37763371-03C1D589-8FD9-4570-A09A-F5CC01459587

Q37763371-0943E9D0-6437-4619-AC27-138CD9069D12

Q37763371-0B89331B-B928-4445-A0FF-A21D9893CC07

Q37763371-12823EED-80CF-4739-89F5-01AA4F68CBC8

Q37763371-1286F34A-727C-4D9F-B76A-13006269FA96

Q37763371-1FDF5FBE-863D-4872-8A29-8105E6C91C66

Q37763371-2851B09F-BA66-4115-B231-331249AFF724

Q37763371-328E8186-745C-491D-9C7A-5C07E7F2B64C

Q37763371-3877122C-C942-4C1E-8CBF-963C654F59A9

Q37763371-38D01626-1683-4608-B1C4-54DD3E85C2B6

P304

Q37763371-80A85CA3-91F6-425D-A781-1EF34AC0CC91

P31

Q37763371-4C304415-28F7-4401-8456-B0CD66C9B371

P356

Q37763371-C5067A9C-3C38-4554-A69B-540BF557A09F

P433

Q37763371-41C614BE-1C99-4B9D-82E7-635A834D2C37

P478

Q37763371-8C984D8A-FE1E-4BB4-898D-9FBE5B93F00C

P577

Q37763371-34011557-5D87-49B9-B34F-070A944F7646

P698

Q37763371-97B40F14-94B2-403C-BFED-4B73CE4BF6D2

P921

Q37763371-A51206CC-578E-45AA-BA3F-CB4F0FA10E84

P356

1076029610368670

P1433

Clinical and Applied Thrombosis-Hemostasis

P1476

Risk factors for heart attack, ...... th hormonal contraceptive use.

@en

P2093

Afshin A Divani

http://www.w3.org/2001/XMLSchema#string

Gundu H Rao

http://www.w3.org/2001/XMLSchema#string

Kyle R Brandy

http://www.w3.org/2001/XMLSchema#string

Marilyn S Joseph

http://www.w3.org/2001/XMLSchema#string

Marina Y Zakharova

http://www.w3.org/2001/XMLSchema#string

Pamela J Schreiner

http://www.w3.org/2001/XMLSchema#string

Rachel M Meyer

http://www.w3.org/2001/XMLSchema#string

Yvonne H Datta

http://www.w3.org/2001/XMLSchema#string

P2860

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

Oral contraceptives and myocardial infarction: results of the MICA case-control study

Effects of oral contraceptives on hemostasis and thrombosis.

Benefits and risks of third-generation oral contraceptives.

Oral contraceptives, thrombosis and haemostasis.

Mutation in blood coagulation factor V associated with resistance to activated protein C.

The history of steroidal contraceptive development: the estrogens.

Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa)

Female hormones and thrombosis.

P304

323-331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029610368670

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20530058

http://www.w3.org/2001/XMLSchema#string

P921